Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03506048
Title Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

thyroid gland cancer

Therapies

Lenvatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.